Nasal polyps are painless, soft, and non-risky growth on the nasal lining passages or the sinuses. They usually hang down that look like grapes or teardrops. They are the resultant of the chronic inflammation and are usually related to asthma, allergies, recurring infection, certain immune disorders, and drug sensitivity. The smaller nasal polyps do not have any kind of symptoms, but the larger growth of these polyps can normally block an individual’s nasal passages that could result in breathing issues, lost smell sense, and frequent infections. Nasal polyps can be prevalent in any age groups, but is more common in the adults. The medication for this disorder mostly shrinks the nasal polyps. The surgery option for nasal polyps needs to removal of the polyps. After successful treatment of nasal polyps, most polyps return.
Nasal polyps treatment market was estimated to be over US$ 3.6 Billion in 2018 and is anticipated to grow at a steady CAGR from 2019 to 2030.
The growth of the nasal polyps treatment market can be attributed to a rise in chronic rhinosinusitis among the geriatric population. Nearly 25–30% of chronic rhinosinusitis (crs) cases reported are associated with nasal polyps, which will eventually lead to market growth. In addition, an increase in approvals for nasal polyps treatment by several regulatory bodies is driving the market growth. For instance, in 2019, Dupixent manufactured by Sanofi in partnership with Regeneron Pharmaceuticals Inc., used for the treatment of chronic rhinosinusitis with nasal polyposis (CRSwNP) in adults, received U.S. Food and Drug Administration (FDA) approval. However, the lack of efficacy of pharmacological therapies and high costs associated with nasal polyps treatments restrain market growth.
Major Key Players of the Nasal Polyps Treatment Market are:
OptiNose US, Inc., Regeneron Pharmaceuticals, Inc., Merck & Co., Inc., Pfizer, Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Sanofi, Novartis AG, Intersect ENT, Inc., and AstraZeneca, among others.
Download PDF to Know the Impact of COVID-19 on “Nasal Polyps Treatment Market” at: https://www.marketindustryreports.com/pdf/169
The increasing prevalence of nasal polyps associated with several conditions, such as chronic rhinosinusitis (CRS) and asthma, is contributing to growth of the nasal polyps treatment market. For instance, it is estimated that 25 to 30 percent of the 20 to 32 million U.S. patients suffering from chronic rhinosinusitis (crs) have symptomatic nasal polyps. Similarly, non-invasive procedures are the ones that do not require creating an incision into the body or removal of the tissue. Such non-invasive procedures performed during the removal of nasal polyps by surgery are contributing to market growth owing to patient preferences. For instance, Functional Endoscopic Sinus Surgery (FESS) is a minimally invasive surgical treatment for nasal polyps which is more preferred over polypectomy surgery. Along with the minimal invasive nature of Functional Endoscopic Sinus Surgery (FESS), it also aids in better visualization of critical areas of the nasal passage which significantly improve the precision of surgical processes to remove nasal polyps.
The Nasal Polyps Treatment Market is segmented on the basis of Type of Treatment, End-Users and region.
Major Type of Treatment of Nasal Polyps Treatment Market covered are:
- Pharmacological Therapies
- Surgeries
Major Applications of Nasal Polyps Treatment Market covered are:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
Extensive research for developing novel and more efficient treatment for nasal polyps can also be attributed to growth of the nasal polyps treatment market. For instance, SINUVA a sinus implant that delivers a steroid directly to the sinus, developed by Advanced ENT and Allergy, received FDA approval in 2017 for treating nasal polyps. Similarly, there are many such products, which can be used for the treatment of nasal polyps.
Research objectives:-
– To study and analyze the global Nasal Polyps Treatment consumption (value & volume) by key regions/countries, product type and application, history data.
– To understand the structure of the Nasal Polyps Treatment market by identifying its various sub-segments.
– Focuses on the key global Nasal Polyps Treatment manufacturers, to define, describe and analyze the sales volume, value, market share, market competitive landscape, SWOT analysis, and development plans in the next few years.
– To analyze the Nasal Polyps Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
– To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Have any query? Inquiry about report at: https://www.marketindustryreports.com/inquiry/169
Table of Contents
- INTRODUCTION
- Market Definition
- Market Ecosystem
- Currency Used
- RESEARCH METHODOLOGY
- Research Framework
- Data Collection Technique
- Data Sources
- Market Estimation Methodology
- Data Validation and Triangulation
- ABSTRACT OF THE STUDY
- MARKET DYNAMICS ASSESSMENT
- Overview
- Drivers
- Barriers/Challenges
- Opportunities
- UNIQUE SELLING PROPOSITIONS (USPs)
- Product Pipeline Assessment
- Qualitative Assessment on Novel Treatment Options for Nasal Polyps
- GLOBAL NASAL POLYPS TREATMENT MARKET – ANALYSIS & FORECAST, BY TYPE OF TREATMENT
- Pharmacological Therapies
- Corticosteroids
- Leukotriene Inhibitors
- Antibiotics
- Others
- Surgeries
- Functional Endoscopic Sinus Surgery (FESS)
- Polypectomy
- Pharmacological Therapies
- GLOBAL NASAL POLYPS TREATMENT MARKET – ANALYSIS & FORECAST, BY END-USER
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- GLOBAL NASAL POLYPS TREATMENT MARKET – ANALYSIS & FORECAST, BY REGION
- North America Nasal Polyps Treatment Market
- Europe Nasal Polyps Treatment Market
- Asia Pacific Nasal Polyps Treatment Market
- Rest of the World (ROW) Nasal Polyps Treatment Market
- COMPETITIVE LANDSCAPE ASSESSMENT
- Key Players & Their Competitive Positioning (2018)
- Key Strategies Assessment
- New Product Launches
- Merger & Acquisitions
- Expansions
- Agreements, Collaborations, & Partnerships
- Other Strategies
- COMPANY PROFILES (Business Overview, Product Offered, Financial Performance*, Recent Developments)
- OptiNose US, Inc.
- Regeneron Pharmaceuticals, Inc.
- Merck & Co., Inc.
- Pfizer, Inc.
- F. Hoffmann-La Roche Ltd
- GlaxoSmithKline plc.
- Sanofi
- Novartis AG
- Intersect ENT, Inc.
- AstraZeneca
*Financial details might not be captured in case of privately-held companies or for companies that do not report this information in public domain
Buy Exclusive Report @ https://www.marketindustryreports.com/checkout/169
In the end, Nasal Polyps Treatment industry report specifics the major regions, market scenarios with the product price, volume, supply, revenue, production, and market growth rate, demand, forecast and so on. This report also presents SWOT analysis, investment feasibility analysis, and investment return analysis.
About Market Industry Reports-
Market Industry Reports is a global leader in market measurement & advisory services, Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the caliber of market dynamics & hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research.
We continue to pioneer state-of-the-art approach in research & analysis that makes complex world simpler to stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence we bring proficient contingency to our clients in the evolving world of technologies, megatrends and industry convergence. We empower and inspire Vanguards to fuel and shape their business to build and grow world-class consumer products.
Contact Us-
Email: sales@marketindustryreports.com
Phone: + 91 8956767535
Website: https://www.marketindustryreports.com